Maximum Dose of Norepinephrine
There is no absolute maximum dose of norepinephrine—the FDA label explicitly states that "occasionally much larger or even enormous daily doses (as high as 68 mg base or 17 vials) may be necessary if the patient remains hypotensive," though occult blood volume depletion must always be suspected and corrected at these doses. 1
Standard Dosing Framework
The typical dosing progression follows this pattern:
- Starting dose: 0.1–0.5 mcg/kg/min (approximately 7–35 mcg/min in a 70-kg adult) 2
- Average maintenance: 2–4 mcg/min (0.5–1 mL/min of standard 4 mcg/mL dilution) 1
- Titration: Adjust according to patient response to maintain adequate blood pressure and tissue perfusion 1
When "High Doses" Begin
Recent data-driven analysis identified clinically meaningful thresholds:
- Low dose: <0.2 mcg/kg/min (hospital mortality 14.0%)
- Intermediate dose: 0.2–0.4 mcg/kg/min (hospital mortality 26.4%)
- High dose: >0.4 mcg/kg/min (hospital mortality 40.2%) 3
These cutoffs represent severity stratification rather than absolute contraindications to further escalation.
Critical Clinical Considerations
Before Escalating Norepinephrine Further:
Rule out hypovolemia first - This is the most common reason for apparent norepinephrine "resistance." Central venous pressure monitoring helps detect occult volume depletion 1
Consider adding second vasopressor at 0.2–0.5 mcg/kg/min rather than continuing to escalate norepinephrine alone:
Add inotropic support if cardiac dysfunction present - Consider dobutamine for persistent hypoperfusion despite adequate norepinephrine and volume 4
Consider corticosteroids for refractory shock (hydrocortisone 200 mg/day) 4
Practical Survey Data Shows Wide Variability:
International practice patterns reveal protocolized "maximum doses" ranging from 20–400 mcg/min (non-weight-based) or 0.2–10 mcg/kg/min (weight-based), with median values of 30 mcg/min and 1 mcg/kg/min respectively 5. This variability reflects institutional preferences rather than evidence-based limits.
Key Safety Principles
Doses >0.6 mcg/kg/min are independently associated with higher organ dysfunction (SOFA ≥9 at 24 hours) and likely indicate inadequate volume resuscitation 6. At these doses:
- Reassess volume status aggressively
- Ensure central venous access (peripheral extravasation risk increases, though peripheral administration up to 20 mcg/min appears safe with proper technique) 7
- Monitor for excessive vasoconstriction causing end-organ hypoperfusion
- Have phentolamine 5–10 mg available for extravasation treatment 2
Bottom Line Algorithm
- Start norepinephrine 0.1–0.5 mcg/kg/min
- At 0.2 mcg/kg/min: Reassess volume status thoroughly
- At 0.4–0.5 mcg/kg/min: Add second vasopressor (vasopressin) rather than continuing escalation alone
- At 0.6 mcg/kg/min: Strongly suspect hypovolemia; consider inotrope if cardiac dysfunction present; consider stress-dose steroids
- Beyond 1 mcg/kg/min: Ensure all above steps completed; no absolute ceiling exists but mortality risk substantially elevated
The dose should be titrated to clinical response (adequate perfusion, urine output, lactate clearance) rather than arbitrary numerical limits, but failure to respond at moderate doses demands investigation for correctable causes rather than reflexive escalation.